This solicitation closed on July 28, 2026

View current VETERANS AFFAIRS, DEPARTMENT OF opportunities →
ClosedCONTRACT

AJ11--Synthesis of Cyclic Peptide NPC86

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.248-NETWORK CONTRACT OFFICE 8 (36C248)

Key Details

Agency
VETERANS AFFAIRS, DEPARTMENT OF
Funding Amount
—
Release Date
July 23, 2026
Due Date
July 28, 2026 (Closed)

Official Description

Special Notice Special Notice Page 4 of 4 Non-GMP Synthesis of NP-C86 (Cyclic Peptide) James A. Haley VA Medical Center, 13000 Bruce B. Downs Blvd., Tampa, Florida 33612, intends to solicit sole source to Curia Global Inc., for the NPC86 which is a new drug designed to alleviate metabolic diseases such as T2D and neurodegenerative diseases. The chemistry to synthesize the drug is highly specialized and uses the solid state synthesis method. The target is to synthesize 2 grams of NPC86 which is a...

View on official source

Change History

Opportunity AddedJul 23, 2026 at 1:04 PM

AJ11--Synthesis of Cyclic Peptide NPC86

New SAM.gov opportunity: AJ11--Synthesis of Cyclic Peptide NPC86

Similar Opportunities

Forecast

Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability (CADENCC)

Due September 17, 2026

Active

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Due October 18, 2028

Active

Intent to Sole Source - Quantifying Prediction Error in Two-time Scale Competing Risks Models

Due September 9, 2026

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial